September 21, 2010 08:00 ET

OPTIMIZERx Corp. Announces Updates on SampleMD Launch and Expansion

ROCHESTER, MI--(Marketwire - September 21, 2010) -  OPTIMIZERx Corporation (OTCBB: OPRX) announces the following health systems and updates regarding its SampleMD virtual sample and support platform:

Emory Health System, the largest healthcare system in Georgia with 9,000 employees and more than 20 health centers, has signed an agreement to utilize SampleMD.

Advocate Health Partners, a joint venture between the Advocate Health Care system and 3,600 physicians on the medical staffs of Advocate hospitals, has signed an agreement to utilize SampleMD.

NuHealth System, a Long Island healthcare organization, has signed an agreement to utilize SampleMD.

Saint Barnabas Health Care System, New Jersey's largest integrated healthcare delivery system, has signed an agreement to utilize SampleMD.

Walgreens has signed an agreement with OPTIMIZERx Corp. to promote their prescription, OTC and special savings offers within the SampleMD platform.

OPTIMIZERx Corp. and Allscripts have signed an agreement to offer SampleMD co-pay coupons and e-vouchers for providers to include along with the electronic prescriptions that they are writing for their patients.

OPTIMIZERx anticipates each of the above rollouts to be launched within 4Q, in addition to our upcoming rollouts within Carilion Clinic and Dreyer Medical Centers. Upon this, OPTIMIZERx will have one of the largest, most integrated networks to allow more physicians and patients to receive support to help increase first fill and compliance to prescribed medications.

For more information on OPTIMIZERx Corp., go to or

About OPTIMIZERx Corporation

OPTIMIZERx Corporation provides unique platforms to help patients better afford and comply to their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. For more information about OPTIMIZERx Corp.,


This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Contact Information

  • Contact:
    David Harrell